Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 26:37:11614.
doi: 10.3389/ti.2024.11614. eCollection 2024.

Incidence of De Novo Post-Transplant Malignancies in Thai Adult Kidney Transplant Recipients: A Single-Center, Population-Controlled, Retrospective Cohort Study at the Highest Volume Kidney Transplant Center in Thailand

Affiliations

Incidence of De Novo Post-Transplant Malignancies in Thai Adult Kidney Transplant Recipients: A Single-Center, Population-Controlled, Retrospective Cohort Study at the Highest Volume Kidney Transplant Center in Thailand

Praopilad Srisuwarn et al. Transpl Int. .

Abstract

Kidney transplant recipients (KTRs) are at increased risk of developing de novo post-transplant malignancies (PTMs), with regional differences in types with excess risk compared to the general population. A single-center, population-controlled, retrospective cohort study was conducted at a tertiary care center in Thailand among all adults who underwent their first kidney transplant from 1986 to 2018. Standardized incidence ratios (SIRs) of malignancy by age, sex, and place of residence were obtained using data from the National Cancer Registry of Thailand as population control. There were 2,024 KTRs [mean age, 42.4 years (SD 11.4); female patients, 38.6%] during 16,495 person-years at risk. Of these, 125 patients (6.2%) developed 133 de novo PTMs. The SIR for all PTMs was 3.85 (95% CI 3.22, 4.56), and for pooled solid and hematologic PTMs, it was 3.32 (95% CI 2.73, 3.99). Urothelial malignancies had the largest excess risk, especially in women [female SIR 114.7 (95% CI 66.8, 183.6); male SIR 17.5 (95% CI 8.72, 31.2)]. The next two most common cancers were non-Hodgkin's lymphoma and skin cancer [SIR 20.3 (95% CI 13.6, 29.1) and 24.7 (95% CI 15.3-37.8), respectively]. Future studies are needed to identify the risk factors and assess the need for systematic screening among PTMs with excess risk in KTRs.

Keywords: Thailand; adult; cancer; incidence; kidney transplantation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

None
Graphical abstract
FIGURE 1
FIGURE 1
Flowchart of patients in the study.

Similar articles

Cited by

References

    1. Ying T, Shi B, Kelly PJ, Pilmore H, Clayton PA, Chadban SJ. Death After Kidney Transplantation: An Analysis by Era and Time Post-Transplant. J Am Soc Nephrol (2020) 31(12):2887–99. Epub 20200909. 10.1681/ASN.2020050566 - DOI - PMC - PubMed
    1. Cheung CY, Lam MF, Chu KH, Chow KM, Tsang KY, Yuen SK, et al. Malignancies After Kidney Transplantation: Hong Kong Renal Registry. Am J Transpl (2012) 12(11):3039–46. Epub 20120806. 10.1111/j.1600-6143.2012.04209.x - DOI - PubMed
    1. Jeong S, Lee HS, Kong SG, Kim DJ, Lee S, Park MJ, et al. Incidence of Malignancy and Related Mortality After Kidney Transplantation: A Nationwide, Population-Based Cohort Study in Korea. Sci Rep (2020) 10(1):21398. Epub 2020/12/10. 10.1038/s41598-020-78283-5 - DOI - PMC - PubMed
    1. Yeh CC, Khan A, Muo CH, Yang HR, Li PC, Chang CH, et al. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan. Exp Clin Transpl (2020) 18(2):224–33. Epub 20200304. 10.6002/ect.2019.0210 - DOI - PubMed
    1. Benoni H, Eloranta S, Dahle DO, Svensson MHS, Nordin A, Carstens J, et al. Relative and Absolute Cancer Risks Among Nordic Kidney Transplant Recipients-A Population-Based Study. Transpl Int (2020) 33(12):1700–10. Epub 20200925. 10.1111/tri.13734 - DOI - PMC - PubMed